• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1a型先天性糖基化障碍的不寻常表现:先天性持续性血小板减少症、肥厚型心肌病以及因明显外周水肿呈现的水肿样外观。

Unusual presentation of congenital disorder of glycosylation type 1a: congenital persistent thrombocytopenia, hypertrophic cardiomyopathy and hydrops-like aspect due to marked peripheral oedema.

作者信息

Noelle Vera, Knuepfer Matthias, Pulzer Ferdinand, Schuster Volker, Siekmeyer Werner, Matthijs Gert, Vogtmann Christoph

机构信息

University Children's Hospital, Oststrasse 21-25, 04317 Leipzig, Germany.

出版信息

Eur J Pediatr. 2005 Apr;164(4):223-6. doi: 10.1007/s00431-004-1611-x. Epub 2005 Jan 12.

DOI:10.1007/s00431-004-1611-x
PMID:15645285
Abstract

UNLABELLED

Of the congenital disorder of glycosylation (CDG) syndromes, type 1a is the most common. CDG 1a is a multisystem disorder with a wide clinical spectrum. We report on a term newborn with a severe and fatal clinical course of CDG 1a syndrome. Skin fibroblasts showed a reduced activity of phosphomannomutase 2 (PMM2) and mutation analysis revealed a compound heterozygous PMM2gene mutation (F119L/F157S). Presenting features at birth were hypertrophic non-obstructive cardiomyopathy, "orange-peel" skin, inverted nipples and a hydrops-like aspect due to marked peripheral oedema. Suspected hydrops fetalis was not confirmed due to lack of ascites and pleural effusions. Striking clinical problems were therapy-resistant arterial hypertension, recurrent pericardial and pleural effusions and feeding difficulties with failure to thrive. Persistent congenital thrombocytopenia and hyperferritinaemia in the absence of infection were noted. Bone marrow cytology revealed a macrophage activation of unknown aetiology.

CONCLUSION

Congenital thrombocytopenia, unspecific macrophage activation and a hydrops-like aspect without a real hydrops fetalis broaden the already wide phenotypic spectrum of congenital disorder of glycosylation syndrome type 1a.

摘要

未标注

在先天性糖基化障碍(CDG)综合征中,1a型最为常见。CDG 1a是一种具有广泛临床谱的多系统疾病。我们报告了一例患有严重且致命病程的CDG 1a综合征足月儿。皮肤成纤维细胞显示磷酸甘露糖变位酶2(PMM2)活性降低,突变分析揭示了复合杂合性PMM2基因突变(F119L/F157S)。出生时的表现为肥厚性非梗阻性心肌病、“橘皮样”皮肤、乳头内陷以及因明显外周水肿而呈现的水肿样外观。由于缺乏腹水和胸腔积液,疑似胎儿水肿未得到证实。显著的临床问题包括难治性动脉高血压、反复出现的心包和胸腔积液以及喂养困难伴生长发育迟缓。在无感染情况下发现持续性先天性血小板减少症和高铁蛋白血症。骨髓细胞学检查显示病因不明的巨噬细胞活化。

结论

先天性血小板减少症、非特异性巨噬细胞活化以及无真正胎儿水肿的水肿样外观拓宽了先天性糖基化障碍综合征1a型本已广泛的表型谱。

相似文献

1
Unusual presentation of congenital disorder of glycosylation type 1a: congenital persistent thrombocytopenia, hypertrophic cardiomyopathy and hydrops-like aspect due to marked peripheral oedema.1a型先天性糖基化障碍的不寻常表现:先天性持续性血小板减少症、肥厚型心肌病以及因明显外周水肿呈现的水肿样外观。
Eur J Pediatr. 2005 Apr;164(4):223-6. doi: 10.1007/s00431-004-1611-x. Epub 2005 Jan 12.
2
Congenital disorder of glycosylation type Ia presenting with hydrops fetalis.以胎儿水肿为表现的Ia型先天性糖基化障碍
J Med Genet. 2007 Apr;44(4):277-80. doi: 10.1136/jmg.2006.044735. Epub 2006 Dec 8.
3
Nonimmune hydrops fetalis and congenital disorders of glycosylation: A systematic literature review.非免疫性胎儿水肿与先天性糖基化障碍:系统文献回顾。
J Inherit Metab Dis. 2020 Mar;43(2):223-233. doi: 10.1002/jimd.12162. Epub 2019 Nov 8.
4
Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.96 例 PMM2-CDG(磷酸甘露糖变位酶 2-先天性糖基化障碍)患者的临床、实验室和分子发现及长期随访数据及文献复习。
J Med Genet. 2017 Dec;54(12):843-851. doi: 10.1136/jmedgenet-2017-104903. Epub 2017 Sep 27.
5
Atrial septal defect in a patient with congenital disorder of glycosylation type 1a: a case report.1a型先天性糖基化障碍患者的房间隔缺损:一例报告
J Med Case Rep. 2018 Jan 24;12(1):17. doi: 10.1186/s13256-017-1528-4.
6
Congenital disorder of glycosylation type 1a in a macrosomic 16-month-old boy with an atypical phenotype and homozygosity of the N216I mutation.一名16个月大的巨大儿男孩患有1a型先天性糖基化障碍,具有非典型表型且N216I突变纯合。
Eur J Pediatr. 2003 Oct;162(10):710-3. doi: 10.1007/s00431-003-1278-8. Epub 2003 Aug 2.
7
Congenital disorders of glycosylation with neonatal presentation.伴有新生儿表现的先天性糖基化障碍
BMJ Case Rep. 2014 Apr 16;2014:bcr2013010037. doi: 10.1136/bcr-2013-010037.
8
Congenital Disorder of Glycosylation (CDG) Presenting as Non-immune Hydrops Fetalis.表现为非免疫性胎儿水肿的先天性糖基化障碍(CDG)
Indian J Pediatr. 2016 Apr;83(4):359-60. doi: 10.1007/s12098-015-1895-z. Epub 2015 Sep 14.
9
Severe transient myocardial ischaemia caused by hypertrophic cardiomyopathy in a patient with congenital disorder of glycosylation type Ia.
Eur J Pediatr. 2002 Oct;161(10):524-7. doi: 10.1007/s00431-002-1029-2. Epub 2002 Aug 22.
10
Hypertrophic cardiomyopathy with cardiac rupture and tamponade caused by congenital disorder of glycosylation type Ia.
Pediatr Cardiol. 2012 Jun;33(5):827-30. doi: 10.1007/s00246-012-0214-y. Epub 2012 Feb 29.

引用本文的文献

1
Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.心肌病,一种罕见的糖基化先天性疾病表型:基线筛查和随访评估建议。
Mol Genet Metab. 2024 Aug;142(4):108513. doi: 10.1016/j.ymgme.2024.108513. Epub 2024 Jun 13.
2
Revisiting the immunopathology of congenital disorders of glycosylation: an updated review.重新审视糖基化先天性疾病的免疫病理学:最新综述。
Front Immunol. 2024 Mar 14;15:1350101. doi: 10.3389/fimmu.2024.1350101. eCollection 2024.
3
An oligogenic case of severe neonatal thrombocytopenia and a purportedly benign variant in requiring reinterpretation.

本文引用的文献

1
Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies.先天性糖基化障碍:分子基础、临床表现及特异性治疗的综述
Eur J Pediatr. 2003 Jun;162(6):359-79. doi: 10.1007/s00431-002-1136-0. Epub 2003 Mar 15.
2
Biochemical and molecular studies in 26 Spanish patients with congenital disorder of glycosylation type Ia.对26名患有Ia型糖基化先天性疾病的西班牙患者进行的生化和分子研究。
J Inherit Metab Dis. 2002 Dec;25(8):635-46. doi: 10.1023/a:1022825113506.
3
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders.
一例严重新生儿血小板减少症的寡基因病例和一例需要重新解读的据称良性变异。
Platelets. 2023 Dec;34(1):2237592. doi: 10.1080/09537104.2023.2237592.
4
Metabolic Cardiomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic Review.遗传性碳水化合物代谢紊乱相关的代谢性心肌病和心脏缺陷:系统综述。
Int J Mol Sci. 2023 May 11;24(10):8632. doi: 10.3390/ijms24108632.
5
Inherited Thrombocytopenia Caused by Variants in Crucial Genes for Glycosylation.遗传性血小板减少症由糖基化关键基因变异引起。
Int J Mol Sci. 2023 Mar 7;24(6):5109. doi: 10.3390/ijms24065109.
6
Cystic kidney diseases associated with mutations in phosphomannomutase 2 promotor: a large spectrum of phenotypes.磷酸甘露糖变位酶 2 启动子突变相关的多囊肾病:表型谱广泛。
Pediatr Nephrol. 2021 Aug;36(8):2361-2369. doi: 10.1007/s00467-021-04953-9. Epub 2021 Feb 13.
7
Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway.PMM2-CDG 患者的因子 XII:N-糖基化在接触途径的第一个元件的分泌和功能中的作用。
Orphanet J Rare Dis. 2020 Oct 9;15(1):280. doi: 10.1186/s13023-020-01564-9.
8
New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach.从以人为主的方法对先天性糖基化障碍(CDG)中免疫参与的新见解。
J Clin Med. 2020 Jul 3;9(7):2092. doi: 10.3390/jcm9072092.
9
In Vitro Fertilisation (IVF) Associated with Preimplantation Genetic Testing for Monogenic Diseases (PGT-M) in a Romanian Carrier Couple for Congenital Disorder of Glycosylation Type Ia (CDG-Ia): A Case Report.体外受精(IVF)联合胚胎植入前遗传学检测用于罗马尼亚先天性糖基化障碍 I 型(CDG-Ia)携带者夫妇的单基因疾病(PGT-M):病例报告。
Genes (Basel). 2020 Jun 25;11(6):697. doi: 10.3390/genes11060697.
10
Recognizable phenotypes in CDG.可识别的 CDG 表型。
J Inherit Metab Dis. 2018 May;41(3):541-553. doi: 10.1007/s10545-018-0156-5. Epub 2018 Apr 13.
巨噬细胞活化综合征:风湿性疾病的一种潜在致命并发症。
Arch Dis Child. 2001 Nov;85(5):421-6. doi: 10.1136/adc.85.5.421.
4
Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype.先天性糖基化障碍Ia型(CDG-Ia):R141H/F119L基因型的表型谱
Arch Dis Child. 2001 Sep;85(3):236-9. doi: 10.1136/adc.85.3.236.
5
PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families.在以斯堪的纳维亚家庭为重点的大量1A型先天性糖基化障碍(CDG)家系材料中,PMM2基因突变谱,包括10种新突变。
Hum Mutat. 2000 Nov;16(5):395-400. doi: 10.1002/1098-1004(200011)16:5<395::AID-HUMU3>3.0.CO;2-T.
6
Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).导致糖基化先天性疾病Ia型(CDG-Ia)的磷酸甘露糖变位酶2(PMM2)突变。
Hum Mutat. 2000 Nov;16(5):386-94. doi: 10.1002/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO;2-Y.
7
Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities.1型糖缺乏糖蛋白综合征伴严重血小板减少且磷酸甘露糖变位酶和磷酸甘露糖异构酶活性正常
J Pediatr. 1998 Nov;133(5):697-700. doi: 10.1016/s0022-3476(98)70115-5.
8
Recurrent nonimmune hydrops fetalis associated with carbohydrate-deficient glycoprotein syndrome.与糖蛋白缺乏综合征相关的复发性非免疫性胎儿水肿。
J Inherit Metab Dis. 1998 Aug;21(6):681-2. doi: 10.1023/a:1005496920435.
9
Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A.1A型碳水化合物缺乏糖蛋白综合征中最常见疾病等位基因纯合子的缺失。
Am J Hum Genet. 1998 Mar;62(3):542-50. doi: 10.1086/301763.
10
Haemostatic studies in carbohydrate-deficient glycoprotein syndrome type I.
Thromb Haemost. 1996 Oct;76(4):502-4.